C12N 2770/24222
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/24222 (New viral proteins or individual genes, new structural or functional aspects of) appears on 683 US grants and 703 published applications in this corpus.
Search patents in C12N- Granted patents
- 683
- Published applications
- 703
- Assignees
- 333
- Inventors
- 1,303
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 5 | 0 |
| 1994 | 10 | 0 |
| 1995 | 7 | 0 |
| 1996 | 10 | 0 |
| 1997 | 19 | 0 |
| 1998 | 40 | 0 |
| 1999 | 44 | 0 |
| 2000 | 38 | 0 |
| 2001 | 42 | 4 |
| 2002 | 24 | 44 |
| 2003 | 39 | 85 |
| 2004 | 24 | 44 |
| 2005 | 23 | 51 |
| 2006 | 38 | 53 |
| 2007 | 33 | 41 |
| 2008 | 35 | 39 |
| 2009 | 17 | 48 |
| 2010 | 29 | 49 |
| 2011 | 27 | 49 |
| 2012 | 26 | 35 |
| 2013 | 28 | 22 |
| 2014 | 23 | 23 |
| 2015 | 20 | 19 |
| 2016 | 11 | 15 |
| 2017 | 16 | 16 |
| 2018 | 10 | 8 |
| 2019 | 10 | 4 |
| 2020 | 7 | 10 |
| 2021 | 10 | 8 |
| 2022 | 2 | 8 |
| 2023 | 3 | 7 |
| 2024 | 2 | 8 |
| 2025 | 4 | 9 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Transient expression of biologic materials17 Mar 2026US 12,576,041 B1
- Method of purifying whole virus particles16 Dec 2025US 12,497,598 B2Hvidovre Hospital
- Chimeric antigen receptor polypeptides and methods of using same18 Nov 2025US 12,473,344 B2The Board of Trustees of the Leland Stanford Junior University
- Hepatitis c virus E1/E2 heterodimers and methods of producing same21 Jan 2025US 12,202,859 B2The Governors of the University of Alberta
- Chimeric antigen receptor (CAR) modulation21 Jan 2025US 12,202,863 B2Trustees of Boston University
- Zika and hcv attenuated viruses and use thereof2 Jul 2026US 2026/0185060 A1Bar-Ilan University
- Chimeric Antigen Receptor Polypeptides and Methods of Using Same16 Apr 2026US 2026/0103504 A1The Board of Trustees of the Leland Stanford Junior University
- Hcv antigens and antibodies19 Mar 2026US 2026/0078172 A1The Johns Hopkins University
- Vsv vector-encoded hcv envelope proteins e1/e2 as vaccines against hepatitis c virus15 Jan 2026US 2026/0015593 A1Twincore Zentrum FüR Experimentelle Und Klinische Infektionsforschung GmbH
- Self-cleaving polyproteins and uses thereof6 Nov 2025US 2025/0339512 A1The University of Melbourne
Most cited
By later US patents
- Compositions and methods for delivery of genetic material184US 5,739,118 AApollon Inc. · 1998
- HCV immunoassays employing C domain antigens147US 5,350,671 AChiron Corporation · 1994
- Gas inlet for a plurality of reactant gases into reaction vessel142US 5,441,703 AAixtron SE · 1995
- Methods, primers and probes for detection of hepatitis C and novel variants107US 5,527,669 AHoffmann-La Roche Inc. · 1996
- Compositions and methods for treatment of hepatitis C virus-associated diseases99US 6,174,868 B1Isis Pharmaceuticals, Inc. · 2001